Monoclonal Antibody News and Research

RSS
Monoclonal antibodies (MAbs) are produced from a single B cell clone and can bind to a single type of antigen binding site. MAbs are homogenous antibodies that cannot form lattices with monomeric proteins as they can bind to only a single epitope on the antigen. Developed in the 1970s, MAbs can be produced against any given substance. Thus they can be used to detect and purify any substance of interest. This has made MAbs a powerful tool of molecular biology, biochemistry, and medicine.
FDA approves Aloxi injection for prevention of postoperative nausea and vomiting

FDA approves Aloxi injection for prevention of postoperative nausea and vomiting

Glioblastoma multiforme responds to new treatment

Glioblastoma multiforme responds to new treatment

ImClone Systems enrols first patient in clinical trial of IMC-1121B to treat liver cancer

ImClone Systems enrols first patient in clinical trial of IMC-1121B to treat liver cancer

XYNTHA approved for teatment of hemophilia A by FDA

XYNTHA approved for teatment of hemophilia A by FDA

New method for detecting HER2 breast cancer

New method for detecting HER2 breast cancer

Study looks at safe dosages of the isotope astatine-211 for brain tumors

Study looks at safe dosages of the isotope astatine-211 for brain tumors

Genmab reaches milestones in Ofatumumab collaboration

Genmab reaches milestones in Ofatumumab collaboration

Morphotek announces agreement for development of antibodies to treat prostate cancer

Morphotek announces agreement for development of antibodies to treat prostate cancer

Sanofi Pasteur enters agreement eith Crucell for next-generation biologicals against rabies

Sanofi Pasteur enters agreement eith Crucell for next-generation biologicals against rabies

Study shows that antiangiogenic agent delays progression of advanced breast cancer

Study shows that antiangiogenic agent delays progression of advanced breast cancer

Herceptin helps women with multiple chromosomes containing HER2 gene

Herceptin helps women with multiple chromosomes containing HER2 gene

Vaccinex receives new European patent for antibody discovery technology

Vaccinex receives new European patent for antibody discovery technology

Morphotek issued new U.S patent for method to enhance the affinity of monoclonal antibodies

Morphotek issued new U.S patent for method to enhance the affinity of monoclonal antibodies

Cancers successfully treated by targeting the viruses that cause them

Cancers successfully treated by targeting the viruses that cause them

Light activated magic bullets zap out cancers

Light activated magic bullets zap out cancers

Preventing lung scarring may extend lives of lung cancer patients

Preventing lung scarring may extend lives of lung cancer patients

Emerging cancer therapies and novel targets

Emerging cancer therapies and novel targets

Breakthrough reveals important human receptor structure that will aid drug development

Breakthrough reveals important human receptor structure that will aid drug development

Lilly and MacroGenics to develop and commercialize teplizumab

Lilly and MacroGenics to develop and commercialize teplizumab

Abbott creates one molecule with two antibody functions

Abbott creates one molecule with two antibody functions

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.